RxDoctor Payments DataLook up a doctor →

Clarice Hart, NP

Adult Health · Amherst, NYNPI 1073190542

Payments from drug & device makers

$16,070in general payments, 2019–2025

Across 769 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • GSK$1K
  • Boehringer Ingelheim$992
  • plus $7K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie120$2,428
Lilly USA, LLC100$1,498
Novo Nordisk68$1,411
AstraZeneca(2 entities)22$1,249
GSK51$1,026
Boehringer Ingelheim56$992
UCB, Inc.31$786
Takeda Pharmaceuticals U.S.A., Inc.63$766
Amgen38$697
Exact Sciences20$489
Johnson & Johnson(2 entities)13$366
Pfizer15$297
Axsome Therapeutics, Inc.4$291
Astellas Pharma US Inc11$285
Biocryst US Sales Co., LLC15$276
E.r. Squibb & Sons, L.L.C.8$240
Phathom Pharmaceuticals, Inc.6$206
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$196
Teva Pharmaceuticals USA, Inc.5$192
Viatris Specialty LLC6$175
Kowa Pharmaceuticals America, Inc.10$152
Bayer9$148
Regeneron Healthcare Solutions, Inc.7$139
Merck7$135
Abbott6$135
Jazz Pharmaceuticals Inc.1$125
Mayne Pharma Commercial LLC1$111
IBSA Pharma Inc.6$102
Mylan Specialty L.p.6$93
Amarin Pharma, Inc.6$90
Sun Pharmaceutical Industries Inc.1$84
Grifols USA, LLC3$64
Daiichi Sankyo Inc.3$64
Novartis4$62
Insulet Corporation3$61
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$51
Sobi, Inc3$50
Sanofi-aventis U.S. LLC3$43
Aurinia Pharma U.S., Inc.2$41
Mallinckrodt Hospital Products Inc.2$41
Blueprint Medicines Corporation1$34
Idorsia Pharmaceuticals US Inc2$33
Vanda Pharmaceuticals Inc.2$31
CSL Behring1$30
Incyte Corporation1$28
Ionis Pharmaceuticals, Inc.1$28
Medtronic2$26
Ultragenyx Pharmaceutical Inc.1$22
Boston Scientific1$21
Scilex Pharmaceuticals Inc.1$20
Biogen1$20
GRT US Holding, Inc.1$19
Sandoz1$17
Celltrion USA Inc.1$16
Genentech USA, Inc.1$16
Paratek Pharmaceuticals, Inc.1$14
Eisai Inc.1$14
Dexcom, Inc.1$13
Bio Products Laboratory USA, Inc.1$12

How this compares

$16,070 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York →

Medicare billing

Part B allowed, 2024
$27,709
Medicare patients
125
Services billed
419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Amherst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →